DescriptionMediPharm Labs Corp has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulation without first receiving a cannabis cultivation license. The focus on cannabis concentrates from current Good Manufacturing Practices and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to produce purified, pharmaceutical-grade cannabis oil and concentrates for derivative products. The company has invested in the research-driven team, technology, downstream extraction methodologies and purpose-built facilities to deliver safe and precisely-dosed cannabis products to patients and consumers.
Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.
Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.
A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.
What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.
Latest Press Releases
|Period||Period Low||Period High||Performance|
|1-Month|| 0.52 +11.54% increase |
| 0.98 -40.82% decrease |
| -0.23 (-28.40%) decrease |
|3-Month|| 0.52 +11.54% increase |
| 1.10 -47.27% decrease |
| -0.47 (-44.76%) decrease |
|52-Week|| 0.52 +11.54% increase |
| 4.44 -86.94% decrease |
| -3.03 (-83.93%) decrease |